B-cell acute lymphoblastic leukemia (B-cell ALL) is a type of blood cancer that affects B lymphocytes, which are white blood cells found in the bone marrow that develop into cells and aid in immunity. B-cell acute lymphoblastic leukemia (B-cell ALL) is a type of blood cancer (leukemia) in which too many B-cell lymphoblasts (immature B …
Read More »Tag Archives: cancer
SCLC vs. NSCLC: Which Lung Cancer Type is More Aggressive?
While NSCLC is the more common type of lung cancer, it is slow-growing and far less aggressive than SCLC. Non-small cell lung cancer (NSCLC) carries a better prognosis than small cell lung cancer (SCLC). NSCLC is slow-growing, whereas SCLC grows far more aggressively. Additionally, NSCLC is the more common type, accounting for 85 percent of cases, whereas SCLC is rarer, …
Read More »Stage III Lung Cancer Lifespan & Survival Rate
The lifespan and survival rate of patients diagnosed with stage III lung cancer depends on the type and subtype of the cancerous tumor. Typically, there are four stages for any cancer progression, with each stage representing the extent or spread, number and size of the tumor in the body. After identifying the stage, doctors decide the right treatment and can …
Read More »Is Non-Small Cell Lung Cancer Aggressive? NSCLC Lifespan
NSCLC is slow-growing and less aggressive than SCLC, which means the survival rate and lifespan are better compared to other types of lung cancer. Lung cancer is one of the deadliest forms of cancer with many deaths that surpass the three most common cancers combined (colon, breast and pancreatic). There are two main types of lung cancer based on the …
Read More »Stage IV Cancer Lifespan & Survival Rate: Is There a Cure?
While stage IV lung cancer is hard to cure, advancements in cancer treatments may help improve your lifespan and survival rate, depending on your overall state of health. Your doctor is the best person to talk to when it comes to your cancer diagnosis and outlook. Fortunately, cancer research has grown rapidly in the last few years, and the lifespan …
Read More »What Is the Survival Rate for Stage I Lung Cancer?
Typically, the survival rate for stage I lung cancer is anywhere from 70 to 92 percent, depending on the type. Early diagnosis and treatment can improve the outlook. Lung cancer, the third most common type of cancer, is the leading cause of cancer-related deaths worldwide. Though it can be fatal, early diagnosis and treatment can improve the outlook. However, survival …
Read More »What Percentage of Abnormal Mammograms Are Cancer?
Only 0.5% of women with abnormal mammograms are found to have breast cancer Being told that your mammogram is abnormal can be terrifying, but there’s no need to panic. Of all women who get regular mammograms, only about 0.5% will be found to have breast cancer. So if you are summoned back to the doctor’s office for further testing after …
Read More »Types of Ovarian Cancer Medications
Your doctor may prescribe a treatment plan that includes different types of ovarian cancer medications Ovarian cancer medications are drugs prescribed to treat cancers of the ovaries. Surgery is usually the initial treatment for ovarian cancer, to remove as much of the cancer as safely possible and to stage the cancer. Medications are systemic treatments used in all stages to …
Read More »Nerlynx (neratinib): Breast Cancer Treatment Side Effects & Dosage
Generic drug: neratinib Brand name: Nerlynx What is Nerlynx (neratinib), and how does it work? Nerlynx (neratinib) is a prescription medicine used alone to treat adults with early-stage human epidermal growth factor receptor 2 (HER2)-positive breast cancer and who have previously been treated with trastuzumab-based therapy. Nerlynx is also used with a medicine called capecitabine to treat adults with HER2-positive …
Read More »Yescarta (axicabtagene ciloleucel): Cancer Drug Side Effects & Dosage
Generic drug: axicabtagene ciloleucel Brand name: Yescarta What is Yescarta (axicabtagene ciloleucel), and how does it work? Yescarta (axicabtagene ciloleucel) is a CD19-directed genetically modified autologous T cell immunotherapy indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy, including diffuse large B-cell lymphoma (DLBCL) not otherwise specified, …
Read More »